Valproate in the treatment of epilepsy in girls and women of childbearing potential-Reference-Cited by-同舟云学术

Valproate in the treatment of epilepsy in girls and women of childbearing potential

Published:2015-05-16 Issue:7 Volume:56 Page:1006-1019
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Tomson Torbjörn¹,Marson Anthony²³,Boon Paul⁴,Canevini Maria Paola⁵,Covanis Athanasios⁶,Gaily Eija⁷,Kälviäinen Reetta⁸⁹,Trinka Eugen¹⁰¹¹¹²

Affiliation:

1. Department of Clinical Neuroscience; Karolinska Institutet; Stockholm Sweden

2. Department Molecular and Clinical Pharmacology; University of Liverpool; Liverpool United Kingdom

3. The Walton Centre NHS Foundation Trust; Liverpool United Kingdom

4. Reference Center for Refractory Epilepsy; Ghent University Hospital; Ghent Belgium

5. Epilepsy Center; Department of Health Sciences; San Paolo Hospital; University of Milan; Milan Italy

6. Department of Neurology; The Children Hospital “Agia Sophia”; Athens Greece

7. Department of Pediatric Neurology; Children's Hospital; University of Helsinki and Helsinki University Hospital; Helsinki Finland

8. Department of Neurology; School of Medicine; University of Eastern Finland; Kuopio Finland

9. Kuopio Epilepsy Center; Kuopio University Hospital; Kuopio Finland

10. Department of Neurology; Christian Doppler Klinik; Paracelsus Medical University Salzburg; Salzburg Austria

11. Centre for Cognitive Neuroscience; Salzburg Austria

12. Department of Public Health and Health Technology Assessment; UMIT - Health & Life Sciences University; Hall in Tirol Austria

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.13021/fullpdf

Reference63 articles.

1. European Medicines Agency Assessment Report. Procedure Under Article 31 of Directive 2001/83/EC Resulting from Pharmacovigilance Data 2014 http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Valproate_and_related_substances_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500177352.pdf

2. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse;Nau;Toxicol Appl Pharmacol,1985

3. Valproate and the risk of congenital malformations: is formulation and dosage regime important?;Mawhinney;Seizure,2012

4. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry;Tomson;Lancet Neurol,2011

5. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study;Meador;Lancet Neurol,2013

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiation of Antiseizure Medications by US Board-Certified Neurologists After a First Unprovoked Seizure Based on EEG Findings;Neurology Clinical Practice;2024-02

2. Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?;Epilepsia;2024-01-31

3. Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy;Neurology;2024-01-23

4. Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study;Scientific Reports;2024-01-05

5. The modern approaches to the diagnostics and treatment of Lennox–Gastaut syndrome (literature review);Russian Journal of Child Neurology;2024-01-03